Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and metformin both help treat PCOS, but using them together works best.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Patients with metabolic syndrome often have skin problems like acanthosis nigricans and skin tags, and early treatment is important to prevent serious issues.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Melatonin improved mental health and metabolism in women with PCOS.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Women with hirsutism have different levels of omentin-1, which may be linked to the condition and its genetic aspects.